Company profile for Orthogon Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Orthogon Therapeutics is a biotechnology company specializing in the development of first-in-class antiviral small molecule drugs using biophysics- and structure-based drug design. Their primary focus is on creating orally administrable treatments targeting polyomaviruses, particularly the BK virus, which poses significant risks to immunocompromised patients, especially transplant recipients. Orthogon has developed small molec...
Orthogon Therapeutics is a biotechnology company specializing in the development of first-in-class antiviral small molecule drugs using biophysics- and structure-based drug design. Their primary focus is on creating orally administrable treatments targeting polyomaviruses, particularly the BK virus, which poses significant risks to immunocompromised patients, especially transplant recipients. Orthogon has developed small molecule drugs that directly target viral proteins essential to the polyomavirus life cycle.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
45 Dan Road Suite 126 Canton, MA 02021
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty